4.7 Article

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis

Nancy de los angeles Segura-Azuara et al.

Summary: Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most prevalent liver disorder worldwide. Non-invasive scoring systems can accurately diagnose MAFLD and assess its severity. However, further validation studies in different populations are needed to obtain more accurate diagnostic results.

FRONTIERS IN MEDICINE (2022)

Article Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

Zobair M. Younossi et al.

Summary: Based on data analysis from the 2019 Scientific Registry of Transplant Recipients, NASH was the second most common indication for liver transplantation in 2019 and the fastest increasing indication. In 2019, NASH was the leading indication for liver transplantation among women without HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Real-World Burden of Nonalcoholic Steatohepatitis

Andreas Geier et al.

Summary: In this study analyzing data from NASH patients in the United States, France, and Germany, it was found that NASH is associated with increased healthcare resource use and reduced HRQoL in symptomatic patients. The burden of NASH appears to be underestimated and further studies are needed to determine the burden of NASH by fibrosis stage and disease severity.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Inverse Association Between Fatty Liver at Baseline Ultrasonography and Remission of Type 2 Diabetes Over a 2-Year Follow-up Period

Hajime Yamazaki et al.

Summary: The study revealed that patients with fatty liver had a lower rate of type-2 diabetes remission over a 2-year follow-up period, while improvement of fatty liver was significantly associated with a higher rate of type-2 diabetes remission.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

Ramy Younes et al.

Summary: This study compared various non-invasive scoring systems in identifying risk and predicting long-term outcomes for patients with non-alcoholic fatty liver disease. NFS, HFS, and FIB-4 outperformed APRI and BARD in both cross-sectional identification of fibrosis and prediction of long-term outcomes, making them useful tools for clinical management of NAFLD patients at increased risk of fibrosis and liver-related complications or death.

JOURNAL OF HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review

Luca Rinaldi et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MS) share similar features, with insulin resistance being a key factor. Lifestyle changes can improve symptoms, and there is a correlation between diabetes and multiorgan damage.

ANTIOXIDANTS (2021)

Article Medicine, General & Internal

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Philip N. Newsome et al.

Summary: This phase 2 trial demonstrated that treatment with semaglutide resulted in a significantly higher percentage of patients with NASH resolution compared to placebo in patients with NASH, but did not show a significant between-group difference in the percentage of patients with an improvement in fibrosis stage.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease

Raffaele Galiero et al.

Summary: There is a strong association between Nonalcoholic Fatty Liver Disease (NAFLD) and increased cardiovascular (CV) risk, possibly due to mechanisms such as insulin resistance, inflammation, oxidative stress, and triglyceride accumulation. Studies have shown that NAFLD is related to preclinical atherosclerotic damage and various cardiovascular events. Treatment of NAFLD may have an impact on cardiovascular outcomes.

REVIEWS IN CARDIOVASCULAR MEDICINE (2021)

Review Gastroenterology & Hepatology

Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets

Cristiana Bianco et al.

Summary: Fatty liver disease can be caused by a combination of factors such as excess alcohol consumption, dysmetabolism, and environmental cues, leading to steatohepatitis and potentially severe liver conditions like liver failure and hepatocellular carcinoma. Recent genetic discoveries have shed light on the causes of steatohepatitis, opening up new possibilities for more targeted risk assessment and potential therapeutic developments. This knowledge could pave the way for precision medicine approaches tailored to individuals at higher risk of liver diseases.

JHEP REPORTS (2021)

Article Gastroenterology & Hepatology

Epidemiology of chronic liver diseases in the USA in the past three decades

Zobair M. Younossi et al.

Review Gastroenterology & Hepatology

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Decreased Quality of Life Is Significantly Associated With Body Composition in Patients With Nonalcoholic Fatty Liver Disease

Niharika Samala et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis

Diego Martinez-Urbistondo et al.

ANTIOXIDANTS (2020)

Article Medicine, General & Internal

Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome

Chuan-Chuan Liu et al.

MEDICINE (2019)

Article Public, Environmental & Occupational Health

Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial

Miguel A. Martinez-Gonzalez et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Fabio Marra et al.

JOURNAL OF HEPATOLOGY (2018)

Article Multidisciplinary Sciences

Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

Inigo Galilea-Zabalza et al.

PLOS ONE (2018)

Article Gastroenterology & Hepatology

The Relationship between NAFLD and Sarcopenia in Elderly Patients

Yu Zhai et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Treatment of NAFLD with diet, physical activity and exercise

Manuel Romero-Gómez et al.

JOURNAL OF HEPATOLOGY (2017)

Article Medicine, General & Internal

The TyG index may predict the development of cardiovascular events

Laura Sanchez-Inigo et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Endocrinology & Metabolism

The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome

Nancy E. Aguilar-Olivos et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Health Care Sciences & Services

Relationship of moderate alcohol intake and type of beverage with health behaviors and quality of life in elderly subjects

Elizabeth Gonzalez-Rubio et al.

QUALITY OF LIFE RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Mediterranean diet, moderate-to-high intensity training, and health-related quality of life in adults with metabolic syndrome

L. Landaeta-Diaz et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)

Article Gastroenterology & Hepatology

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

Jeong-Hoon Lee et al.

DIGESTIVE AND LIVER DISEASE (2010)

Article Nutrition & Dietetics

Anti-inflammatory effects of the Mediterranean diet: the experience of the PREDIMED study

Ramon Estruch

PROCEEDINGS OF THE NUTRITION SOCIETY (2010)

Article Medicine, General & Internal

Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome Status One-Year Results of the PREDIMED Randomized Trial

Jordi Salas-Salvado et al.

ARCHIVES OF INTERNAL MEDICINE (2008)